Reaction

Carbohydrate Antigen 125 Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,396 reports · 57 co-occurring drugs

As of the last recalculation, Carbohydrate Antigen 125 Increased appears in 3,396 FAERS reports alongside 57 co-occurring drug terms. The strongest observed disproportionality signal is NIRAPARIB (PRR 1,118.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Niraparib	1,848	1,118.4	1,220.5
Rucaparib	571	476.2	509.3
Olaparib	300	96.3	97.7
Standardized Senna Concentrate	37	18.2	18.3
Prochlorperazine	54	12.1	12.1
Bevacizumab	215	11.3	11.3
Doxorubicin Hydrochloride	55	10.5	10.5
Prochlorperazine Maleate	15	10.0	10.0
Dronabinol	12	9.2	9.2
Docusate Sodium - Sennosides	47	9.0	9.1
Letrozole	85	8.6	8.7
Magnesium	105	8.0	8.1
Ado-Trastuzumab Emtansine	11	8.0	8.0
Docusate Sodium	72	7.8	7.8
Sennosides 8.6 Mg Tablets	26	7.7	7.7
Senna	26	7.6	7.6
Senna Leaf	28	7.5	7.5
Letrozole Tablets	54	7.0	7.0
Biotin	35	6.9	6.9
Sennosides	33	6.8	6.8
Anastrozole Tablets	22	6.3	6.3
Docusate Sodium 100Mg	24	6.2	6.2
Magnesium Oxide	41	6.1	6.1
Lisinopril And Hydrochlorothiazide	9	5.4	5.4
Methylprednisolone Acetate	7	5.4	5.4
Vitamin C	78	5.3	5.3
Carboplatin	105	5.2	5.2
Ribociclib	25	4.9	4.9
Anastrozole	29	4.9	4.9
Magnesium Sulfate In Water For	10	4.8	4.8
Polyethylene Glycol 3350	73	4.8	4.8
Ondansetron Hydrochloride	93	4.8	4.8
Zinc	19	4.7	4.7
Magnesium Sulfate Heptahydrate	10	4.7	4.7
Zinc Chloride	19	4.7	4.7
Magnesium Sulfate	10	4.7	4.7
Granisetron	8	4.7	4.7
Phenobarbital	11	4.7	4.7
Ondansetron	81	4.6	4.6
Ondansetron Tablets	81	4.6	4.6
Melatonin	40	4.5	4.5
Fulvestrant	24	4.5	4.5
Thiamine Hydrochloride, Riboflavin 5 Phosphate Sodium, Dexpanthenol And Niacinamide	21	4.3	4.3
Drs. Clotrimazole	8	4.2	4.3
Family Wellness Clotrimazole	8	4.2	4.3
Clotrimazole Topical	8	4.2	4.3
Midazolam	17	4.1	4.2
Midazolam Hydrochloride	18	4.1	4.1
Paclitaxel (Aibumin-Bound)	49	3.7	3.7
Paclitaxel	56	3.5	3.5
Pembrolizumab	55	3.2	3.2
Gemcitabine	20	3.1	3.1
Lisinopril And Hydrochlorothiazide Tablets	4	3.1	3.1
Gemcitabine Hydrochloride	25	2.9	2.9
Lenvatinib	14	2.6	2.6
Fam-Trastuzumab Deruxtecan-Nxki	3	1.8	1.8
Copper	3	0.4	0.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.